NCT06002477View on ClinicalTrials.gov

Attentional Mechanisms in SCD

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Subjective Cognitive Decline
Interventions
DRUG

Mecamylamine Challenge

Mecamylamine 20 mg oral pill administered once

OTHER

Placebo Comparator Challenge

Matching placebo oral pill administered once

Trial Locations (1)

37212

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER